Title:
NOVEL BIFIDOBACTERIUM LONGUM STRAIN AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2022/239916
Kind Code:
A9
Abstract:
The present invention relates to a novel Bifidobacterium longum strain and use thereof and, more particularly, to a novel Bifidobacterium longum subsp. Infantis YB0411 strain having anti-obesity activity, and a pharmaceutical composition, a health functional food, a cosmetic composition, a feed composition, a reagent composition, or the like for anti-obesity use, comprising a culture of the strain. The strain culture of Bifidobacterium longum subsp. Infantis YB0411 with the accession number of KCTC14393BP of the present invention has an inhibitory effect on the maturation process of pre-adipocytes into adipocytes. Thus, the strain culture can be applied for use in an anti-obesity pharmaceutical composition, health functional food, cosmetic composition, feed composition, reagent composition, and the like. Furthermore, when pre-adipocytes are treated with the strain culture of the present invention, the maturation of the pre-adipocytes into adipocytes may be inhibited, and thus the present invention can be actively utilized for research on the development of therapeutic agents related to obesity or the like.
Inventors:
KIM YONG-SIK (KR)
RHAMAN MD SHAMIM (KR)
KANG INSEOK (KR)
RHAMAN MD SHAMIM (KR)
KANG INSEOK (KR)
Application Number:
PCT/KR2021/015958
Publication Date:
December 22, 2022
Filing Date:
November 04, 2021
Export Citation:
Assignee:
BTGIN CO LTD (KR)
International Classes:
C12N1/20; A23L33/135; A61K8/99; A61K35/745; A61P3/04; A61Q19/06; A23K10/16; C12N5/077; C12R1/01
Attorney, Agent or Firm:
SUH, Jang-Chan et al. (KR)
Download PDF: